Medical Journals Publishing
Login


International Journal of Cognitive Neuroscience and Psychology

 Submit manuscript

CLINICAL VERIFICATION OF THE ROLE OF INFLAMMATION MARKERS IN CHRONIC BRAIN ISCHEMIA

Vol. 4 No. 1 (2026): International Journal of Cognitive Neuroscience and Psychology:
Published : Jan 10, 2026

Abdullayeva Nargiza Nurmamatovna (1), Djurabekova Aziza Takhirovna (2), Doniyorov Davlatbek Raufovich (3)

(1) Doctor of Medical Sciences, Professor of the Department of Neurology Samarkand State Medical University, Uzbekistan
(2) Doctor of Medical Sciences, Professor, Head of the Department of Neurology Samarkand State Medical University, Uzbekistan
(3) Master of the Department of Neurology of Samarkand State Medical University, Uzbekistan
Fulltext View | Download

Abstract:

Persistent neurological, cognitive, and psycho-emotional disorders are determined by a high level of disability and a decrease in the quality of life of patients due to chronic cerebrovascular disorders. According to foreign epidemiological studies, signs of chronic cerebrovascular disorders are detected in 30-40% of individuals over 55 years of age, and in recent years, there has been a trend towards the "rejuvenation" of vascular cerebral pathology.

References

1. Azizova R.B. Chronic Cerebrovascular Diseases: Clinical and Pathogenetic Aspects. Neurology and Neurosurgery of Uzbekistan. 2015;2:12-17.

2. Gusev E.I., Skvorsova V.I. Chronic forms of cerebrovascular diseases: pathogenesis, clinical presentation, diagnosis. Journal of Neurology and Psychiatry named after S.S. Korsakov. 2016;116 (6):4-11.

3. Daminova F.A., Bobomurodova Z.B. Inflammatory markers as predictors of the progression of chronic cerebral ischemia. Journal of Neurology of Uzbekistan. 2022;3:30-35

4. Zakharov V.V., Yakhno N.N. Cognitive impairments in chronic cerebral ischemia. Neurological Journal. 2020;25 (2):9-15.

5. Kalashnikova L.A., Gulevskaya T.S. The role of neural inflammation in the formation of chronic cerebral ischemia. Achievements of modern biology. 2019;139 (4):321-329.

6. Madjidova Yo.N. Cognitive impairments in chronic cerebral ischemia and ways to correct them. Journal of Theoretical and Clinical Medicine. 2019;4:45-49.

7. Parfenov V.A. Chronic cerebral ischemia: modern concepts of diagnosis and treatment. Medical advice. 2021;3:18-24.

8. Rakhimbayeva G.S. The role of systemic inflammation in the pathogenesis of cerebral vascular diseases. Bulletin of Samarkand State Medical University. 2021;1:38-43.

9. Skvorsova V.I., Shamalov N.A. Inflammation and Endothelial Dysfunction in Cerebrovascular Diseases. Annals of clinical and experimental neurology. 2018;12 (3):25-32.

10. Tuychibayeva N.M., Khamraev Kh.Kh. Clinical and diagnostic approaches in chronic cerebrovascular disorders. Medical Journal of Uzbekistan. 2020;6:22-27.Dinarello C.A. Overview of the IL-1 family in innate inflammation and acquired immunity. Immunological Reviews. 2018;281(1):8–27.

11. Iadecola C. The neurovascular unit coming of age: a journey through neurovascular coupling in health and disease. Neuron. 2017;96(1):17–42.

12. Iadecola C., Anrather J. The immunology of stroke: from mechanisms to translation. Nature Medicine. 2020;26(5):654–663.

13. Ilkhomovna K. M., Kadyrovich K. N., Eriyigitovich I. S. Clinical and demographicquality of life for patients with ischemic stroke in Uzbekistan //ACADEMICIA: An International Multidisciplinary Research Journal. – 2020. – Т. 10. – №. 10. – С. 883-889.

14. Kamalova M., Khaidarov N. Assessment of quality of life in ischaemic stroke patients //Збірник наукових праць Scientia. – 2021.

15. Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurology. 2010;9(7):689–701.

16. Ridker P.M. Inflammation, C-reactive protein, and cardiovascular disease. Circulation Research. 2016;118(1):145–156.

17. Wardlaw J.M., Smith C., Dichgans M. Small vessel disease: mechanisms and clinical implications. Lancet Neurology. 2019;18(7):684–696.